Donna McIntosh

Title: Donna McIntosh: Innovator in Cancer Diagnostics and Treatment

Introduction

Donna McIntosh is a prominent inventor based in Chelmsford, MA (US). She has made significant contributions to the field of cancer diagnostics and treatment through her innovative research and patented methods. With a total of 2 patents, her work focuses on improving patient outcomes in oncology.

Latest Patents

One of her latest patents is titled "Predicting tumor response to anti-ERBB3 antibodies." This diagnostic method aims to quantitatively predict whether a human tumor will be sensitive or resistant to treatment with an ERBB3 inhibitor, such as an anti-ERBB3 antibody. The method relies on measuring NRG1 expression at the RNA or protein level in a tissue sample from the tumor. Another significant patent is "Synthesis of oligo/poly(catechins) and methods of use." This patent describes a method for synthesizing a biocompatible, water-soluble oligo/polyflavanoid. The process involves polymerizing an optionally substituted flavanoid with a polymerization agent in the presence of a biocompatible polymerization solubilizer. This innovation has potential applications in treating cancer, cardiac damage, viral infections, and obesity.

Career Highlights

Throughout her career, Donna McIntosh has worked with notable organizations, including Aveo Pharmaceuticals, Inc. and the University of Massachusetts. Her experience in these institutions has allowed her to develop and refine her innovative approaches to cancer treatment and diagnostics.

Collaborations

Some of her coworkers include Sylvie Vincent and Kristan Meetze. Their collaborative efforts have contributed to the advancement of research in the field of oncology.

Conclusion

Donna McIntosh's work exemplifies the impact of innovation in the medical field, particularly in cancer diagnostics and treatment. Her patents reflect a commitment to improving patient care and advancing scientific knowledge.